Breast Cancer Management

Scope & Guideline

Transforming Breast Cancer Care Through Collaboration.

Introduction

Immerse yourself in the scholarly insights of Breast Cancer Management with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1758-1923
PublisherFUTURE MEDICINE LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Converge2013, 2016, from 2018 to 2019, from 2021 to 2024
AbbreviationBREAST CANCER MANAG / Breast Cancer Manag.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND

Aims and Scopes

The journal 'Breast Cancer Management' focuses on advancing knowledge in the field of breast cancer through various research methodologies, clinical studies, and real-world evidence. Its core areas include clinical management, risk assessment, treatment evaluation, and innovative therapeutic approaches.
  1. Clinical Management of Breast Cancer:
    The journal emphasizes clinical studies that explore management strategies for different breast cancer subtypes, including HR+/HER2-, triple-negative, and HER2+ cancers.
  2. Real-World Evidence and Cohort Studies:
    There is a strong focus on real-world data analyses and retrospective cohort studies that evaluate treatment outcomes and survival rates in diverse patient populations.
  3. Innovative Diagnostic Techniques:
    Research on advanced imaging modalities, such as MRI, and their effectiveness in diagnosing and evaluating breast cancer is a consistent area of interest.
  4. Risk Factors and Epidemiology:
    The journal covers investigations into the epidemiology of breast cancer, including the identification of risk factors and demographic studies across different regions.
  5. Emerging Therapeutic Approaches:
    The journal explores the effectiveness of new therapeutic agents and regimens, such as CDK4/6 inhibitors, particularly in specific patient groups.
  6. Focus on Male Breast Cancer:
    Male breast cancer is highlighted as a unique area of research, examining its diagnosis, treatment, and outcomes, which are often underrepresented in breast cancer literature.
Recent publications in 'Breast Cancer Management' reveal emerging themes that reflect the evolving landscape of breast cancer research. These trends indicate a growing emphasis on personalized medicine, advanced treatment modalities, and a deeper understanding of breast cancer biology.
  1. Personalized Medicine and Targeted Therapies:
    There is an increasing focus on targeted therapies, particularly in the context of specific breast cancer subtypes like HR+/HER2- and triple-negative breast cancer, which highlights the shift towards personalized treatment approaches.
  2. Real-World Data Analysis:
    The trend of utilizing real-world data to assess treatment effectiveness and patient outcomes is gaining momentum, providing insights that complement clinical trial findings.
  3. The Role of Imaging in Treatment Planning:
    Research on the use of advanced imaging techniques, particularly MRI, is becoming more prevalent, indicating its importance in preoperative evaluation and treatment strategies.
  4. Survivorship and Long-Term Outcomes:
    Emerging themes related to survivorship, including long-term outcomes and survival analysis in diverse patient groups, are increasingly prominent as researchers seek to understand the long-term impacts of breast cancer treatments.
  5. Increased Focus on Male Breast Cancer:
    The growing body of research dedicated to male breast cancer suggests an emerging recognition of this underrepresented area, addressing unique clinical challenges and experiences.

Declining or Waning

While the journal covers a wide array of topics in breast cancer research, certain themes have shown a decline in publication frequency or relevance over the recent years. This may indicate a shift in research focus or a saturation of existing knowledge in those areas.
  1. Complementary and Alternative Medicine:
    Research on alternative treatments, such as osteopathy for breast cancer, appears to be less prominent, suggesting a waning interest in non-conventional therapies in favor of evidence-based clinical practices.
  2. Case Reports and Isolated Incidents:
    The frequency of case reports, particularly those detailing unique or rare instances of breast cancer, seems to be declining, possibly due to a preference for larger cohort studies that provide more generalizable results.
  3. Socio-Cultural Factors in Breast Cancer Awareness:
    While studies on attitudes toward molecular testing in specific populations have been published, this theme seems to be less frequently explored in recent years, indicating a potential shift in focus towards more clinical or treatment-oriented research.

Similar Journals

Imagerie de la Femme

Transforming Imaging Modalities for Women’s Care
Publisher: ELSEVIER MASSON, CORP OFFISSN: 1776-9817Frequency: 4 issues/year

Imagerie de la Femme, published by ELSEVIER MASSON, is a pivotal journal in the field of women’s health and surgical practices, holding an ISSN of 1776-9817 and an E-ISSN of 2214-8485. Established in 2005 and converging through to 2024, this journal is dedicated to disseminating high-quality research and innovative findings that contribute to the understanding and advancement of surgical techniques and imaging modalities specifically tailored to women. Despite its current Q3 ranking in Surgery and Scopus rank of 536/551, the journal is increasingly recognized for its focus on emerging trends and critical issues within the discipline. As a scholarly platform, it offers an essential resource for researchers, healthcare professionals, and students alike, promoting knowledge exchange and fostering advancements in the nuanced realm of female surgical health. With its commitment to enhancing clinical practice and patient outcomes, Imagerie de la Femme plays an important role in shaping future research and educational efforts in this vital area of medicine.

World Journal of Oncology

Transforming oncology through shared knowledge and discovery.
Publisher: ELMER PRESS INCISSN: 1920-4531Frequency: 12 issues/year

The World Journal of Oncology, published by ELMER PRESS INC, is a vibrant platform for disseminating groundbreaking research and advancements in the field of oncology. With its ISSN 1920-4531 and E-ISSN 1920-454X, this journal is dedicated to publishing high-quality studies that enhance our understanding of cancer and its treatment. The journal is recognized for its significant contributions, evidenced by its Q2 classification in both Cancer Research and Oncology categories in 2023, and accolades such as a Scopus rank of #126/404 in Medicine _ Oncology. Catering to the needs of researchers, professionals, and students, the World Journal of Oncology offers an essential resource for the latest scientific insights and clinical practices, ensuring the global oncology community remains informed and engaged. The journal operates under a selective publication model, maintaining rigor in peer review while facilitating knowledge sharing across converged years from 2014 to 2016 and 2020 to 2024, further establishing its importance in the ongoing fight against cancer.

Bladder Cancer

Transforming knowledge into patient care in urology.
Publisher: IOS PRESSISSN: 2352-3727Frequency: 4 issues/year

Bladder Cancer, published by IOS PRESS, is a premier open access journal dedicated to advancing the field of oncology and urology, with a specific focus on bladder cancer research and treatment. Established in 2015 and continuing through to 2024, this journal aims to disseminate high-quality, peer-reviewed research that contributes to the understanding, diagnosis, and management of bladder cancer, a critical area of concern in urological oncology. With a robust publication record now encompassing open access since 2023, Bladder Cancer ensures accessibility to vital research for clinicians, researchers, and scholars worldwide. The journal's rankings in Scopus reflect its commitment to excellence, holding a Q3 category in both oncology and urology, with Scopus ranks of #78 in Urology and #285 in Oncology, showcasing its growing influence in the scientific community. By fostering dialogue and innovation, Bladder Cancer serves as an essential resource for those committed to improving patient outcomes in bladder oncology.

BREAST CANCER RESEARCH AND TREATMENT

Exploring New Frontiers in Oncology
Publisher: SPRINGERISSN: 0167-6806Frequency: 18 issues/year

Breast Cancer Research and Treatment, published by Springer, stands as a pivotal journal within the domains of Cancer Research and Oncology, exemplified by its impressive Q2 and Q1 quartile rankings, respectively, in the 2023 category rankings. Since its inception in 1981, this journal has provided a vital platform for disseminating cutting-edge research focused on all aspects of breast cancer, ranging from molecular biology to treatment strategies. With an ISSN of 0167-6806 and E-ISSN of 1573-7217, it captures a broad audience of researchers, clinicians, and students dedicated to improving patient outcomes. The journal emphasizes high-quality, peer-reviewed studies that pave the way for advancements in therapy and direct novel insights into oncological practices. By maintaining a strong ranking in Scopus with percentile placements of 74th in Oncology and 61st in Cancer Research, Brest Cancer Research and Treatment continues to foster innovation and collaboration in the fight against breast cancer.

Breast Cancer

Empowering breakthroughs in oncology and pharmacology.
Publisher: SPRINGER JAPAN KKISSN: 1340-6868Frequency: 6 issues/year

Breast Cancer is a prestigious peer-reviewed journal published by SPRINGER JAPAN KK, specializing in the multifaceted domains of oncology and medical pharmacology. With an impressive impact factor and recognized within the Q1 category in multiple areas, including Medicine (miscellaneous), Radiology, and Nuclear Medicine and Imaging, this journal serves as a fundamental resource for cutting-edge research and clinical advancements in breast cancer treatment and care. Its indexed presence in renowned databases like Scopus further affirms its significance, ranking 56th in Radiology and 60th in Pharmacology. The journal aims to bridge the gap between clinical practice and scientific research by publishing original articles, reviews, and case studies that enhance understanding and improve patient outcomes. With converged content available from 1994 to 2024, the journal is dedicated to fostering innovative research while engaging a global audience of researchers, clinicians, and students passionate about tackling breast cancer challenges.

Breast Cancer-Basic and Clinical Research

Empowering discoveries in breast cancer care.
Publisher: SAGE PUBLICATIONS LTDISSN: 1178-2234Frequency: 1 issue/year

Breast Cancer-Basic and Clinical Research is a premier open access journal published by SAGE Publications Ltd, dedicated to advancing the understanding and treatment of breast cancer through a comprehensive approach that integrates basic and clinical research findings. Since its inception in 2008, this journal has aimed to serve as a vital platform for researchers, healthcare professionals, and students in the fields of oncology and cancer research, providing them with timely access to significant new research, clinical trials, and innovative methodologies. With its current rankings placing it in the Q3 quartile for Cancer Research and Oncology, it reflects a steady commitment to quality and relevance, ranking #167/404 in Medicine - Oncology and #133/230 in Biochemistry, Genetics and Molecular Biology - Cancer Research as of 2023. The journal is designed to foster dialogue and collaboration across disciplines, enabling advancements in therapeutic strategies and patient care. Researchers and professionals will find it an invaluable resource as it continues to push the frontiers of knowledge in breast cancer research.

Current Breast Cancer Reports

Innovating Strategies for Breast Cancer Care.
Publisher: SPRINGERISSN: 1943-4588Frequency: 4 issues/year

Current Breast Cancer Reports is a vital academic journal published by Springer that focuses on the latest research and advancements in the field of breast cancer. With its ISSN 1943-4588 and E-ISSN 1943-4596, this journal serves as an essential resource for oncologists, researchers, and healthcare professionals dedicated to improving diagnosis and treatment strategies for breast cancer. Spanning from 2009 to 2024, it provides a platform for high-quality, peer-reviewed articles that encompass a range of topics, including molecular biology, clinical trials, and innovative therapeutic approaches. Although it is currently classified in the Q3 category in Oncology and is positioned in the 29th percentile, the journal remains committed to elevating its academic impact and contributing meaningfully to the ongoing fight against breast cancer. As it seeks to disseminate critical findings and foster collaboration within the scientific community, Current Breast Cancer Reports is poised to be an indispensable tool for anyone keen on advancing the field.

World Journal of Clinical Oncology

Uniting Global Experts in Clinical Oncology
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 2218-4333Frequency: 12 issues/year

World Journal of Clinical Oncology, published by BAISHIDENG PUBLISHING GROUP INC, stands as a vital resource in the realm of oncology, providing a dedicated platform for the dissemination of cutting-edge research and clinical advancements. With an ISSN of 2218-4333, this journal facilitates a comprehensive exploration of modern oncology challenges and breakthroughs, targeting researchers, healthcare professionals, and students alike. Although it operates under the traditional subscription model, the impactful nature of its content is reflected in its notable ranking of 60 out of 334 in the category of Medicine _ Oncology, placing it in the 82nd percentile among peer publications. Covering significant topics in clinical oncology from 2014 to 2018, the journal has been instrumental in addressing evolving oncology practices and patient care innovations. By publishing high-quality studies, it remains an essential tool for advancing knowledge and fostering collaboration within the global oncology community.

Journal of Gastrointestinal Cancer

Shaping the future of gastrointestinal oncology.
Publisher: SPRINGERISSN: 1941-6628Frequency: 4 issues/year

Journal of Gastrointestinal Cancer, published by SPRINGER, stands as a crucial resource in the fields of Gastroenterology and Oncology. With an ISSN of 1941-6628 and E-ISSN of 1941-6636, this journal has been committed to advancing the understanding and treatment of gastrointestinal cancers since its inception in 2007 and is poised to continue until 2024. The journal is recognized in the Q3 quartiles for both Gastroenterology and Oncology as of 2023, reflecting its relevance and contribution to these vital areas of medical research. Despite not being an open-access journal, it offers printed and online subscription options for access, ensuring that valuable research reaches the hands of practitioners, researchers, and students alike. With a focus on disseminating original research, reviews, and case studies, the Journal of Gastrointestinal Cancer plays a pivotal role in fostering ongoing education and discovery in the fight against cancer, promoting better patient outcomes worldwide. The journal is also indexed in Scopus, with notable rankings in the 50th and 45th percentiles for Gastroenterology and Oncology, respectively, further underscoring its scientific merit and credibility in the academic community.

Oncology Letters

Exploring New Frontiers in Cancer Treatment and Care
Publisher: SPANDIDOS PUBL LTDISSN: 1792-1074Frequency: 12 issues/year

Oncology Letters is a prominent academic journal dedicated to disseminating high-quality research in the fields of oncology and cancer research. Published by SPANDIDOS PUBL LTD and based in Greece, this journal has established a significant presence since its inception in 2010 and continues to contribute to the scientific community with a focus on both clinical and experimental oncology. Notably, it holds a respectable Q3 ranking in the categories of Cancer Research and Oncology as of 2023, highlighting its relevance and contribution to these critical fields. With a Scopus rank of #139/404 in Medicine – Oncology and #117/230 in Biochemistry, Genetics, and Molecular Biology – Cancer Research, Oncology Letters serves as a valuable platform for researchers, professionals, and students alike to explore emerging findings and innovative treatment approaches. Though it operates within a traditional subscription model, this journal prides itself on fostering accessible and impactful discourse in oncology, making it an essential resource for those committed to advancing cancer research and improving patient care.